Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep M Llibre

Showing results (111-120 of 162) with videos related to

Pageof 17
Sort By:
International Journal of Environmental Research and Public Health|February 25, 2023
Determinants of Depressive Symptoms in People Living with HIV: Findings from a Population-Based Study with a Gender PerspectiveIvet Bayes-Marin, Laia Egea-Cortés, Jorge Palacio-Vieira, et al.
Antiviral Therapy|May 11, 2011
Baseline CD4(+) T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patientsJonathan M Schapiro, Charles A B Boucher, Daniel R Kuritzkes, et al.
BMC Public Health|August 29, 2021
Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping reviewJorge Palacio-Vieira, Juliana Maria Reyes-Urueña, Arkaitz Imaz, et al.
Open Forum Infectious Diseases|January 15, 2024
Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score-Matched AnalysisDaniel K Nomah, Yesika Díaz, Andreu Bruguera, et al.
AIDS Care|August 18, 2025
Where did they go? Describing and reengaging people with HIV lost to follow-up in the PISCIS Cohort StudyJorge Palacio-Vieira, Sergio Moreno-Fornés, Yesika Díaz, et al.
Current HIV Research|July 16, 2009
The changing face of HIV/AIDS in treated patientsJosep M Llibre, Vicenç Falco, Cristina Tural, et al.
Plos One|January 30, 2014
Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individualsAi Kawana-Tachikawa, Josep M Llibre, Isabel Bravo, et al.
Microorganisms|January 21, 2022
SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune SuppressionHortensia Álvarez, Ezequiel Ruiz-Mateos, Pedro Miguel Juiz-González, et al.
The Lancet. HIV|August 5, 2024
Identifying risk factors for anal cancer in people with HIV in Spain: a multicentre retrospective cohort study nested in the PISCIS cohortJosep M Llibre, Boris Revollo, Jordi Aceiton, et al.
The Lancet. HIV|October 16, 2021
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort studyDaniel K Nomah, Juliana Reyes-Urueña, Yesika Díaz, et al.
Pageof 17

Showing results (111-120 of 162) with videos related to

Sort By:
Pageof 17
International Journal of Environmental Research and Public Health|February 25, 2023
Determinants of Depressive Symptoms in People Living with HIV: Findings from a Population-Based Study with a Gender PerspectiveIvet Bayes-Marin, Laia Egea-Cortés, Jorge Palacio-Vieira, et al.
Antiviral Therapy|May 11, 2011
Baseline CD4(+) T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patientsJonathan M Schapiro, Charles A B Boucher, Daniel R Kuritzkes, et al.
BMC Public Health|August 29, 2021
Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping reviewJorge Palacio-Vieira, Juliana Maria Reyes-Urueña, Arkaitz Imaz, et al.
Open Forum Infectious Diseases|January 15, 2024
Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score-Matched AnalysisDaniel K Nomah, Yesika Díaz, Andreu Bruguera, et al.
AIDS Care|August 18, 2025
Where did they go? Describing and reengaging people with HIV lost to follow-up in the PISCIS Cohort StudyJorge Palacio-Vieira, Sergio Moreno-Fornés, Yesika Díaz, et al.
Current HIV Research|July 16, 2009
The changing face of HIV/AIDS in treated patientsJosep M Llibre, Vicenç Falco, Cristina Tural, et al.
Plos One|January 30, 2014
Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individualsAi Kawana-Tachikawa, Josep M Llibre, Isabel Bravo, et al.
Microorganisms|January 21, 2022
SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune SuppressionHortensia Álvarez, Ezequiel Ruiz-Mateos, Pedro Miguel Juiz-González, et al.
The Lancet. HIV|August 5, 2024
Identifying risk factors for anal cancer in people with HIV in Spain: a multicentre retrospective cohort study nested in the PISCIS cohortJosep M Llibre, Boris Revollo, Jordi Aceiton, et al.
The Lancet. HIV|October 16, 2021
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort studyDaniel K Nomah, Juliana Reyes-Urueña, Yesika Díaz, et al.
Pageof 17